May 26, 2023 | News, Uncategorized
“One of my primary goals is to bring new, young investigators into the Alpha-1 research community to ensure that we continue to benefit from new ideas and high-quality research for years to come,” said Dr. Andrew Wilson, Alpha-1 Foundation Scientific Director. The...
Mar 15, 2023 | News, Uncategorized
We are writing to let you know that there is a nationwide shortage of albuterol. Albuterol is used to treat asthma symptoms, which could potentially heighten with more pollen in the air triggering allergies. The resources listed below can help you make the...
Dec 21, 2022 | News, Uncategorized
CSL Behring asked leaders in patient advocacy to share examples of creativity and innovation in 2022. Learn what they’re most proud of and how good ideas took shape in the past year. December 20, 2022- This year, we’ve been turning to therapist Jodi Taub with...
Dec 19, 2022 | News, Uncategorized
Wave Life Sciences recently hosted Alpha Dan Coffin and his wife Kathi at their offices to speak with employees about living with Alpha-1. Shortly thereafter, Wave announced a collaboration with GSK that will provide GSK with the exclusive global license to Wave’s...
Dec 6, 2021 | News, Uncategorized
November 29, 2021 The Honorable A. Donald McEachin (D-VA) House of Representatives Washington, DC 20515 The Honorable Rodney Davis (R-IL) House of Representatives House of Representatives Washington, DC 20515 Dear Congressman McEachin and Congressman Davis, We are...
Nov 15, 2021 | News, Uncategorized
The Alpha-1 Foundation convened the third Virtual Alpha-1 Lobby Day on Wednesday, November 10, 2021 during the annual Alpha-1 Awareness Month. This officially marked one year since the first-ever virtual lobby day for the community. Once again, Alpha-1 advocates came...
